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Abstract
A bioinformatics comparison of Salmonella Pathogenicity Island 3 sequences from S. Typhi and S. Typhimurium serovars
showed that ten genes are highly conserved. However three of them are pseudogenes in S. Typhi. Our aim was to
understand what functions are lost in S. Typhi due to pseudogenes by constructing a S. Typhi genetic hybrid carrying the
SPI-3 region of S. Typhimurium instead of its own SPI-3. We observed that under stressful conditions the hybrid strain
showed a clear impairment in resistance to hydrogen peroxide and decreased survival within U937 culture monocytes. We
hypothesized that the marT-fidL operon, encoded in SPI-3, was responsible for the new phenotypes because marT is a
pseudogen in S. Typhi and has a demonstrated role as a transcriptional regulator in S. Typhimurium. Therefore we cloned
and transferred the S. Typhimurium marT-fidL operon into S. Typhi and confirmed that invasion of monocytes was
dramatically decreased. Finally, our findings suggest that the genomic and functional differences between SPI-3 sequences
have implications in the host specificity of Typhi and Typhimurium serovars.
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Introduction
The Salmonella enterica genome has five DNA regions that are
relatedtopathogenicityand aresharedby all serovars,referred to as
the Salmonella pathogenicity islands (SPI). The acquisition of these
SPI regions seems to have played a major role in the adaptation of
Salmonella to new niches in its vertebrate hosts, supporting many
bacterial requirements during infection [1]. One such island, SPI-3,
is located in the selC locus of S. enterica and contains ten ORFs [2],
some of them have been experimentally associated with virulence
functions in this pathogen. This is the case of the mgtCB operon, for
which there is evidence of involvement in intramacrophage survival
and virulence in mice [3–5]. This operon is encoded in all Salmonella
serovars within a very conserved SPI-3 region [6]. The mgtC seems
to be a pathogenic factor that has been repeatedly acquired by
horizontal gene transfer throughout bacterial evolution, because it
has also been related to virulence in Mycobacterium tuberculosis and
Brucella suis [7–9].
Other SPI-3 genes that have a role in pathogenicity are misL
and marT. The misL gene encodes an autotransporter protein that
is involved in the adhesion of S. enterica serovar Typhimurium (S.
Typhimurium) to the extracellular matrix in mice and chicks,
thereby acting as an intestinal colonization factor [10,11]. It has
also been shown that marT encodes a transcriptional regulator that
activates the expression of misL [12]. However, both MisL and
MarT are absent from the virulence repertoire of some Salmonella
serovars, because their nucleotide sequences have acquired
translational stop codons and are considered pseudogenes. This
is the case in S. enterica serovar Typhi (S. Typhi), a human-specific
pathogen that causes Typhoid fever, a life-threatening and
systemic infection of higher incidence in developing countries [13].
The remaining SPI-3 ORFs encode conserved hypothetical
proteins that have not been experimentally characterized [14].
There are three pseudogenes in the published SPI-3 sequence of
S. Typhi CT18 [15], which is consistent with previous reports
establishing that almost 5% of the S. Typhi gene repertoire is
composed of pseudogenes, many of which are encoded in
pathogenicity islands [4]. The disruption or inactivation of this
amount of genome sequences suggests that S. Typhi has lost the
ability to express several virulence-associated functions, a condi-
tion of biological relevance that may explain the invasive nature
and human-restricted host specificity of this pathogen.
To further contribute to the growing knowledge of the SPI-3 in
Salmonella and the functional effects of the structural differences
observed, we transferred the complete S. Typhimurium SPI-3
island into a S. Typhi clinical strain and then characterized some
of the phenotypic effects on the pathogenicity of the recombinant
strain. The main findings were related to a higher susceptibility to
oxidative stress and a lower survival rate inside human monocytic
cell line. In order to elucidate some of the protein functions
involved in these phenotypes, we cloned the S. Typhimurium
marT-fidL operon in a low copy number plasmid. When present in
a S. Typhi wild-type strain, this operon significantly affected the
early survival of bacteria inside monocytic cells, giving a partial
explanation for the phenotypes described with the recombinant
SPI-3 bacterium.
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Bacterial Strains and Culture Media
A clinical isolate of S. Typhi, designated STH2370, was
obtained from the Infectious Diseases Hospital Lucio Co ´rdova
in Santiago, Chile. The strain has been described previously [16],
and was isolated directly from the blood sample taken from a
typhoid patient, grown to overnight density, and frozen as a
primary stock. The S. Typhimurium reference strain 14028s was
obtained from the Instituto de Salud Pu ´blica, Santiago, Chile.
The strains were grown routinely in liquid culture in Luria-Bertani
(LB) medium (Bacto Tryptone, 10 g/L; Bacto Yeast Extract, 5 g/L;
NaCl, 5 g/L) adjusted to pH 7 (NaHPO4/NaH2PO4 25 mM), at
37uC, with aeration provided by shaking, or anaerobically, prior to
invasion assays in cultured human cells [17]. When required, the
medium was supplemented with kanamycin (Kan; 50 mg/mL),
chloramphenicol (Cam; 20 mg/mL), and/or gentamycin (Gem;
10 mg/mL). Media were solidified by the addition of agar (15 g/L).
Construction of a S. Typhi Genetic Hybrid Containing the
SPI-3 Region of S. Typhimurium
To characterize the new properties conferred on the S. Typhi
STH2370 strain upon the introduction of the entire S. Typhimur-
ium SPI-3 region, the exchange of this complete island sequence
was performed by homologous recombination using both the
lambda Red recombinase system [18] and a generalized
transduction with the P22 HT105/1 int201 phage [19]. Briefly,
the Kan
R cassette was amplified with the primers SPW3 (59-AG-
AGAAAGTGGAATATTATTTTATTAATCACCATTTACC-
GTGTAGGCTGGAGCTGCTTCG-39) and SPW4 (59-C-
GTTAGTCCTGGCGTACTTTTATCCCTTCTTTGCAGA-
CGACATATGAATATCCTCCTTAG-39), and was inserted at
the left end of the S. Typhimurium 14028s SPI-3 island (Fig. 1).
The Cam
R cassette (chloramphenicol resistance, codified in the
pKD3 plasmid), amplified with primers MGW1 (59-ATGGAG-
GAACGTATGTTAATGTTTCCTTATATTTTAAATTTG-
TAGGCTGGAGCTGCTTCG-39) and MGW2 (59-TGACC-
CACGAGCTCGGCACGAATTTCTTTATAGCCCTGTTC-
ATATGAATATCCTCCTTAG-39) was placed at the right end
of the S. Typhi STH2370 SPI-3 island (Fig. 1). A P22 HT105/1
int201 phage lysate of the 14028 Kan
R strain was subsequently
produced and used for the generalized transduction of the
STH2370 Cam
R strain. S. Typhi clones that had acquired the
Kan
R but lost the Cam
R phenotype were then selected. Using this
procedure the hybrid S. Typhi SPI-3 STm (SPI-3 STm) strain was
obtained, and the exchange of the pathogenicity island sequences
was confirmed by PCR (data not shown).
To exclude the possibility that the S. Typhimurium SPI-3 flanking
sequences might be contributing to the phenotypic modifications in
the S. Typhi transformants, the 14028s DSPI-3::aph mutant strain
wasconstructed using the lambda Red recombinasesystem [18] with
the primer pair SPW1 (59-AACGCAGGCGCTACGTTTGTC-
GATGCCGTAACTTTCTGAATGTAGGCTGGAGCTGCTT-
CG-39) and SPW2 (59- GCTAAATATAGCACGTACTTAT-
TCTTCCAGAAAAAATGGACATATGAATATCCTCCTTA-
G-39) (Fig. 1). Later the P22 HT105/1 int201 phage lysate obtained
from this strain was used to transduce STH2370 cells. The
transference of this mutation was also confirmed by PCR.
Construction of Mutant Strains
The mutant strains were constructed using the lambda Red
recombinase methodology, as previously described [18]. The
primer pairs used were T66W1 (59- TTCTTGCTGGAAAAA-
CTGGCGTGTAATGCTGAAGAATTCATGTAGGCTGGA-
GCTGCTTCG-39) and T66W2 (59- TTTATTCATTGCCAC-
CTCCCTGACTGTTCTCGTTATTTTGCATATGAATATC-
CTCCTTAG -39) for the S. Typhi t3766 mutant strain, CIGW1
(59- CAAATCGTTTTCTAACGAGGTGACGCCATGCAAA-
AAAGAGCATATGAATATCCTCCTTA -39) and CIGW2 (59-
ACGATTTTCCACTCATAGCCCGGATAATAAGGTAATT-
GTCTGTAGGCTGGAGCTGCTTCG -39) for the SPI-3 STm
cigR mutant strain, MISW1 (59- ATGACCTTGTTATCAAAC-
CAGTTGTACAGCATCCAGGTATCATATGAATATCCTC-
CTTA -39) and MISW2 (59- TCGGCCAATATTTACGTCGG-
CGACGATCTGTATATCAAAATGTAGGCTGGAGCTGC-
TTCG -39) for the SPI-3 STm misL mutant strain, and the primers
MARW1 (59- TTTTATAAGGTTGCTGACAAATCAATGCC-
GTAACCGCTGTGTAGGCTGGAGCTGCTTCG -39) and
Figure 1. Genomic organization of Salmonella pathogenicity island 3. A, SPI-3 in S. Typhimurium. B, SPI-3 in S. Typhi. ORFs are depicted by
arrows and tRNAs appear as closed triangles. ORFs with no orthologs between these serovars and pseudogenes are depicted by white and
segmented arrows respectively. The percentage (%) of nucleotide identity of the SPI3 loci is shown in between. The aligning sites of the PCR primers
are shown by black dots.
doi:10.1371/journal.pone.0009394.g001
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GCGATGTTATGGCATATGAATATCCTCCTTA -39) for the
SPI-3 STm marT mutant strain.
Phenotypic Analyses
For the assay of growth in minimal medium, bacteria were
cultured overnight in M9 medium [20] supplemented with 10 mM
MgCl2, 0.2% glucose, tryptophan and cysteine (50 mg/mL each).
Then the culture was washed three times with Mg
+2 free medium,
diluted 1/200 in M9 media containing 10 mM or 10 mM MgCl2,
and incubated with shaking at 37uC. For the assay of growth in
acidic pH, bacteria were grown in LB broth pH 7 at 37uC
overnight with shaking, then were washed three times with LB at
pH 5 (citric acid 0.1 M), diluted 1/200 in the same medium and
incubated with shaking at 37uC. In both assays the bacterial
growth was measured with a spectrophotometer at an optical
density of 600 nm (OD600) for several periods.
To determine bacterial survival after exposure to oxidative
stress, the strain was cultured in 2 mL of LB pH 7 at 37uC
overnight with shaking. Then the culture was diluted 1/100 in LB
pH 7, the H2O2 added to a final concentration of 3 mM and the
culture incubated at 37uC for 30 min with shaking. For the
survival rate analysis, aliquots of cultures were diluted and plated
in triplicate before and after challenge. Survival was expressed as
the percentage of colony forming units (CFU) after the assay
compared to the count before the challenge.
Infection Assays in U937 Human Monocytic Cells
Infection of U937 cells was carried out as described previously
[5]. Briefly, cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% (vol/vol) fetal bovine serum,
seeded into 24-well tissue culture plates at a concentration of 10
5
cells per well, and then incubated at 37uCi n5 %C O 2 until
confluent growth was achieved. Later the cells were centrifuged
and washed three times with PBS. Approximately 2610
6 to
5610
6 CFU of exponential-phase (OD600, 0.15 to 0.20) anaero-
bically grown bacteria were pelleted, washed twice with PBS, and
resuspended in 1 mL of PBS. Aliquots (100 mL) of bacteria were
added to U937 cells at a multiplicity of infection (MOI) of 50:1.
After 1 h of infection, cells were centrifuged and washed three
times with PBS, and the medium was replaced with Dulbecco’s
modified Eagle’s medium supplemented with 10% (vol/vol) fetal
bovine serum containing Gem (200 mg/mL). After additional
incubation for 1 h U937 cells were washed three times with PBS
and lysed with 0.5% deoxycholate for the early survival evaluation
(time 2 h) or were incubated for 23 h in fresh medium containing
Gem (25 mg/mL) for late survival evaluation (time 24 h). When
assayed Gem resistant strains, the antibiotic used was Kan (50 mg/
mL for 1 h and 20 mg/mL thereafter) instead of Gem. The titers of
intracellular bacteria were determined by serial dilution of cell
lysates on agar plates. The percentage of survival was calculated at
2 h considering the initial inoculate as 100%, and at 24 h
considering the CFU counted at 2 h as 100%.
Cloning and Complementation of the marT-fidL Operon
To clone the marT-fidL operon, we amplified a 2.1-kb fragment
of serovar Typhimurium 14028s DNA that included the operon
coding sequence and 699 bp of the marT upstream region using
the primer pair MART1 (59-CTGCAGCTGATGACAG-
TAATCCGTTG-39) and FID2 (59-GAATTCTGATCTT-
CAGCGGCTTTTAC-39) (Fig. 1). The PCR fragment was
purified, digested with endonucleases PstI and EcoRI, and ligated
to the same sites of the Gem
R, low copy-number plasmid vector
pBBR-5 [21]. The ligation mixture was electroporated into E. coli
DH5a, and the white colonies that grew on LB medium plates
containing Gem were screened. Plasmid DNA purified from one
clone yielded an insert of the predicted size after digestion with the
same PstI and EcoRI endonucleases (data not shown), and was
later electroporated into S. Typhi strain STH2370.
RNA Isolation and RT-PCR
Total RNA was extracted and purified using Trizol and was
treated with RNase-free DNase I (amplification grade; Gibco-
BRL). RT-PCR was performed with 500 ng of DNase-treated
RNA using the Superscript reverse transcriptase (Invitrogen).
Amplification was performed for 30 cycles (94uC for 40 s, 55uC for
40 s, and 72uC for 1.5 min, followed by a 10 min extension at
72uC). The primers used were RTMART1 (59- AAACCGTCTC-
GATAACCGCAT-39) and RTMART2 (59-TCCAGAAAT-
GAATCGCCTGG-39) corresponding to an internal region of
the marT-fidL sequence, and the universal primers 8F and 1498R
were used to amplify 16S rRNA [22]. The transcript of the S.
Typhi t3766 gene was amplified with the primer pair T66D (59-
TCAAAATCTCGCAGCCAGCG-39) and T66R (59-AAAT-
TAATGCAGGGGCGTGG-39) (Fig. 1). Genomic DNA was used
as a positive control, and DNase-treated RNA that had not been
reverse transcribed was used as a negative control. The PCR
product was electrophoresed on 1% agarose gels with ethidium
bromide.
Statistical Analyses
Statistical analyses were performed using the Student’s t-test for
independent samples. Values of P,0.05 were considered signif-
icant. This test was performed using Microsoft ExcelH software.
Results
The S. Typhi Genetic Hybrid Containing the SPI-3 Region
of S. Typhimurium Has Modified Pathogenicity
Associated Phenotypes
Following alignment, comparison of the published SPI-3
homolog sequences from S. Typhi and S. Typhimurium showed
a high degree of nucleotide identity (92% on average), although
this was not homogeneously distributed (Fig. 1). The central and
right regions from both islands appear conserved between these
serovars and the most remarkable differences are a highly
polymorphic region at the left end of the island and the existence
of pseudogenes in the S. Typhi sequence, as mentioned previously.
To determine the pathogenicity functions that are associated
with the polymorphic sequences of SPI-3, we constructed a S.
Typhi hybrid containing the SPI-3 region of S. Typhimurium
instead of its own sequence (SPI-3 STm strain). To validate these
findings, we chose three recombinant clones and the parental
STH2370 wild-type strain and compared their survival or growth
behavior under stressful conditions, including survival to oxygen
and nitric oxide derived radicals, to starvation and to hyperos-
molarity and growth in acid and basic media, at different
temperatures, in anaerobiosis and growth in a low Mg
2+
environment Surprisingly, there were three significantly altered
phenotypes exhibited by the SPI-3 STm strain: an 8-fold lower
survival rate after 30 min of exposure to 3 mM hydrogen peroxide
(Fig. 2A), a 1.5-fold greater growth rate after 12 h of incubation in
pH 5 LB broth (Fig. 2B), an 8-fold and 5-fold lower survival rate
inside U937 monocytic cell line (2 h and 24 h, respectively),
compared to the wild-type S. Typhi strain (Fig. 3).
All recombinant clones consistently had the same growth and
survival rates in the assays, demonstrating that the experimental
S. Typhi Genetic Recombinant
PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9394strategy for the SPI-3 exchange was a robust procedure for
determining the phenotypes reported here.
In the control STH2370 DSPI-3::aph strain, a unique finding
was the inability to grow at a low magnesium concentration
(10 mMM g
2+) (data not shown). This result was expected because
the mgtCB operon was among the deleted genes in this clone, and is
responsible for adaptation to low-Mg
2+ environments in both S.
Typhimurium [3] and S. Typhi [5]. Hence, the modified
phenotypes described in the SPI-3 STm hybrid strain were caused
by genes contained in the S. Typhimurium SPI-3 island when
expressed in the context of the S. Typhi genome.
To study the involvement of the pseudogenes in the modified
phenotypesof SPI-3STm strain, we constructed three strains deleting
one of the following genes misL, marT and cigR. However, these
mutations did not show any difference in the survival to peroxide and
the growth rate in pH 5 (data not shown) nor in the survival rate
inside U937 cells (Fig. 3) in comparison with the hybrid strain. This
result suggests that other sequences, alone or in combination, are
modifying the behavior of the S. Typhi SPI-3 STm strain.
The S. Typhi t3766 Mutant Strain Has a Lower Early
Survival Rate inside Human Cells
Becausethet3766sequenceisnotcodifiedintheS.Typhimurium
SPI-3 island, it is absent from the SPI-3 STm hybrid strain. To
determine whether this deletion could have some effect in the
studied phenotypes, we constructed a S. Typhi t3766 mutant strain
that was tested under the same experimental conditions. A lower
survival rate inside U937 cells at 2 h post infection was the unique
significant finding (p,0.05) that had this t3766 mutant in
comparison with the S. Typhi wild type strain. However, this
susceptibility was not similar to the observed with the SPI-3 STm
strain(Fig. 3A), suggesting that additional factorsare contributingto
the lower intracellular survival of the hybrid strain.
Characterization of the S. Typhimurium marT-fidL Operon
An in silico analysis of sequences from S. Typhimurium SPI-3
suggested that the main factor responsible for the phenotypic
changes observed in the SPI-3 STm hybrid could be marT, since its
protein product exhibits similarity to the putative DNA binding
domain of the CadC transcriptional activator of E. coli K-12,
which has been associated with the acid stress response [2,12,23].
In our current study, we sequenced the marT gene from the clinical
S. Typhi strain STH2370 and confirmed that the same number
and positions of the internal stop codons were present as described
in published S. Typhi Ty2 and CT18 genomes [24]. In addition,
we confirmed that marT and fidL are co-transcribed in S.
Typhimurium strain 14028s (Fig. 4A), this is the reason for
cloning the operon and its promoter in the pBBR-5 plasmid.
When S. Typhi was transformed, the transcription of marT-fidL in
the STH2370/pBmarT (marT-fidL
+) strain was confirmed by RT-
PCR (Fig. 4B). To determine whether the operon could modify the
Figure 2. Phenotypic assays with a S. Typhi genetic hybrid strain. A, Percentage (%) of survival following 30 min exposure to hydrogen
peroxide (3 mM). B, Growth at pH 5, based on the optical density at 600 nm (OD600) at different times (h). The strains used were a S. Typhi STH2370
containing the SPI-3 region of S. Typhimurium (SPI-3 STm) and the STH2370 wild-type strain (WT).Values represent the mean of at least three
independent experiments 6 SD (*p,0.05).
doi:10.1371/journal.pone.0009394.g002
Figure 3. Infection assays in human cells. A, early survival (2 h). B,
late survival (24 h). Percentage of colony forming units (CFU%) inside
U937 human cells. The strains used were the STH2370 wild-type strain
(WT), a S. Typhi STH2370 expressing the SPI-3 of S. Typhimurium (SPI-3
STm), the SPI-3 STm strain containing deletions of marT (DmarT), misL
(DmisL) and cigR (DcigR) sequences, and a S. Typhi STH2370 t3766
mutant strain (Dt3766). The values represent the mean of at least three
independent experiments 6 SD. Different numbers of asterisks
represent significant differences between results (p,0.05).
doi:10.1371/journal.pone.0009394.g003
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pBmarT strain, we aligned the reported binding site of MarT in
the misL promoter [12] against the S. Typhi SPI-3 sequence. The
highest identity (55%) was found in the upstream region of t3766.
In addition, there are two ToxR consensus binding sites
(TTTTGAT) localized both within the t3766 promoter region
and inside its coding sequence. Given that MarT is a member of
the family of ToxR-like regulatory proteins [12], t3766 is a
candidate target for regulation by the marT-fidL products. The
RT-PCR assay showed that the S. Typhimurium marT-fidL operon
represses the transcription of this S. Typhi SPI-3 sequence
(Fig. 4C).
The S. Typhimurium marT-fidL Operon Modifies the Early
Survival of S. Typhi in U937 Monocytic Cell Line
To determine whether the marT-fidL products can affect the
phenotypes described in the SPI-3 STm strain, the STH2370/
pBmarT strain was evaluated in the same assays. The only
significant phenotype arising as a result was a four-fold lower
survival rate after two hours of infection in monocytic U937 cells,
showing the same intracellular survival as the wild-type when
evaluated at 24 h post infection (Fig. 5).
Discussion
The ability to infect and live within an animal host suggests the
existence of multiple pathogenic functions codified in the bacterial
genome, destined to increase fitness under a stressful environment
or to subvert the host response.
Pathogens with a broad host range obviously require more
mechanisms to evade the immune response than those with a
single host. The variety of such additional mechanisms will be in
accordance with the multiplicity of bactericidal mechanisms
displayed by the immune system of susceptible individuals.
In the case of Salmonella serovars, which have a highly similar
genetic background, the differences in host range suggest a
variable number of pathogenic functions codified on the
chromosome, although the size of the chromosomes among
serovars is very similar. This genetic trait is clear when comparing
the serovars Typhi and Typhimurium, with the S. Typhi
pseudogenes being the main cause of this characteristic [4].
However, this global loss of functions observed in S. Typhi
probably implies better adaptation to life within the human body,
as it is not exclusively localized in the intestinal tract, as is the case
with S. Typhimurium [25].
It is possible that SPI-3 and its described variability among
Salmonella serovars [6] could participate in their respective host
specificity and invasive nature by differentially affecting the
bacterial response to some stressful conditions. Here we suggest
two such responses that could be codified on the SPI-3: adaptation
to a pH 5 and survival following hydrogen peroxide damage.
Hence, it is probable that the island has a important role in the
intracellular life of Salmonella by acting not only in response to
magnesium scarcity [2,3,5,26], but also to reactive oxygen species
and acidic environments. However, not all SPI-3-associated
responses will be useful and functional in all serovars because
when some of them are expressed in certain strains, they could
have a negative effect on pathogenic associated phenotypes. This
could be the case of a S. Typhi strain expressing the SPI-3 of S.
Typhimurium. Given the gain of function that should follow the
exchange of genes in place of pseudogenes, our first hypothesis was
that the recombinant strain could be more resistant to some
stressful conditions. However, only growth in acidic medium
supported this hypothesis because in the other two assays (survival
in response to 3 mM H2O2, and infection of U937 monocytic cell
line) the recombinant strain appeared significantly more suscep-
Figure 4. Reverse-transcription PCR assays. A, Amplification of the
marT-fidL internal sequence with RNA extracted from S. Typhimurium.
B, Amplification of the marT-fidL internal sequence. C, Amplification of
the t3766 sequence. In B and C the RNA was extracted from strains
STH2370 wild-type (WT), STH2370/pBBR-5 (WT/pBBR5) and STH2370/
pBmarT (WT/pBmarT). All strains were grown up to the stationary
phase, and the 16S rRNA amplification was used as the control.
doi:10.1371/journal.pone.0009394.g004
Figure 5. The S. Typhimurium marT-fidL operon modifies the
invasiveness of S. Typhi to U937 human cells. Percentage of
colony forming units (CFU%) after invasion (2 h) and proliferation (24 h)
inside U937 human cells. The STH2370 wild-type strain was transformed
with either the pBBR-5 (WT/pBBR5) or pBmarT (WT/pBmarT) plasmids.
Values represent the mean of at least three independent experiments 6
SD (*p,0.05).
doi:10.1371/journal.pone.0009394.g005
S. Typhi Genetic Recombinant
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suggest that pseudogenes were preserved to increase S. Typhi
pathogenicity in the human host.
The specific sequences participating in the phenotypes exhibited
by the recombinant SPI-3 STm strain were not determined,
although the products of the marT-fidL operon can be implicated
by modifying the early survival during infection of U937
monocytes (Fig. 5). This effect could be partially explained by
the ability to represses the transcription of t3766 (Fig. 4C), a
sequence codifying a product with an unknown function that
participates in the early survival of S. Typhi within monocytic cells
(Fig. 3A). However, the presence of the marT-fidL operon confers a
higher susceptibility to intracellular survival than that observed
with the t3766 mutant strain, suggesting that other mechanisms
are involved and demonstrating the regulatory role of the operon
with a potential ability to modulate bacterial responses.
MarT is a member of the family of ToxR-like regulatory
proteins, which are involved in the activation of genes repressed by
the histone-like nucleoid structuring (H-NS) protein [12], and
silences genes with GC contents lower than the genomic average
by restricting the access of RNA polymerases to the DNA [27].
Some previous reports and the results of present study suggest that
a functional and structural homology exists between MarT and
ToxR as i) MarT can bind to the misL promoter region, which has
a low GC content (34.8%) [12] and is also recognized by H-NS
proteins [27]; ii) ToxR is a transcriptional regulator that is
constituted by periplasmic transmembrane and cytosolic domains
[28]. In silico analyses of MarT suggest that this protein has the
same domains described for ToxR (data not shown). iii) ToxR can
sense external stimuli and bind DNA to directly modify the
expression of the regulated genes. In Vibrio cholerae, toxR is co-
transcribed with toxS, a regulatory product that acts as a
chaperone-like protein and stabilizes the periplasmic domain of
ToxR, thus modifying on its function [28,29]. In the case of marT,
it is co-transcribed with fidL, and the phenotypes observed in S.
Typhi require the presence of both genes. When only marT was
cloned and transfer into S. Typhi, none of the phenotypes were
observed (data not shown); and iv) ToxR recognizes the
TTTTGAT sequence in the promoter regions of target genes
[30]. Interestingly, there are some repeats of this consensus
binding site in the SPI-3 coding region of both S. Typhi and S.
Typhimurium. In this work it was found that the S. Typhimurium
marT-fidL operon can repress transcription of S. Typhi t3766
(Fig. 4C), an SPI-3 ORF that contains the consensus TTTTGAT
in both promoter region and the coding sequence.
Some AT-rich pathogenicity islands encode H-NS antagonists
[31,32], indicating that these genetic elements have developed
counter-mechanisms to evade H-NS-mediated silencing [27].
Although other experiments are required to elucidate the role of
the MarT and FidL proteins, it is tempting to speculate that they
belong to the same group of transcriptional regulators that are
encoded in mobile genetic elements and act on AT-rich sequences
to modulate their expression in receptor bacteria. In this
hypothetical situation, the expression of MarT in S. Typhi could
have unexpected effects on several pathogenic associated pheno-
types, probably decreasing the virulence of this human restricted
serovar.
In this work the expression of S. Typhimurium SPI-3 sequences
in S. Typhi indicated previously unknown functions of the island
by clearly modifying some phenotypes of the recombinant strains.
This suggests that pathogenicity islands are evolving in each
serovar of Salmonella with particular characteristics, affecting their
virulence and host specificity. It is interesting that there are
conserved and variable regions within the SPI-3 coding sequence
among serovars [6], probably determining functions that are
similarly required in different host species and other functions that
respond to bacterial requirements in specific hosts.
Finally, the results of this work demonstrate that the
transference of sequences with unknown function between
serovars is an experimental strategy that could help in finding
keys with which to address the study of these poorly known genetic
islands.
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